158 related articles for article (PubMed ID: 8185353)
1. [Evaluation of the anticancer effect of cisplatin and etoposide against nude mice transplanted urological malignant tumors].
Gotoh A; Mizuno Y; Matsuwari S; Kitazawa S; Maeda S; Arakawa S; Kamidono S
Gan To Kagaku Ryoho; 1994 May; 21(6):899-902. PubMed ID: 8185353
[No Abstract] [Full Text] [Related]
2. [Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide].
Hashimoto H; Tokumitsu M; Morikawa M; Numata A; Yachiku S; Iuchi H; Yamauchi K
Gan To Kagaku Ryoho; 1996 Jun; 23(7):941-4. PubMed ID: 8678548
[No Abstract] [Full Text] [Related]
3. [MEC treatment (methotrexate, etoposide, cisplatin) for urothelial cancer].
Miura T; Murai T; Shimura H; Kondo I
Gan To Kagaku Ryoho; 1992 May; 19(5):731-3. PubMed ID: 1580650
[No Abstract] [Full Text] [Related]
4. Therapeutic effect of CDDP and VP-16 against human bladder cancers.
Gotoh A; Mizuno Y; Okada H; Arakawa S; Kitazawa S; Maeda S; Kamidono S
In Vivo; 1995; 9(3):263-7. PubMed ID: 8562894
[TBL] [Abstract][Full Text] [Related]
5. Systemic chemotherapy of murine bladder cancer.
Soloway MS; Niell HB; Matheny RB; Blatnik A
Urology; 1984 Apr; 23(4 Suppl):129-34. PubMed ID: 6538713
[No Abstract] [Full Text] [Related]
6. Neoadjuvant chemotherapy in T3-4 N0-X M0 transitional cell carcinoma of the bladder. Problems of clinical and pathological evaluation of response.
Splinter TA; ten Kate FJ; Schröder FH; Denis L; Newling D; Jones WG; Jacqmin D; Boeken Kruger CG; Stoter G; de Voogt HJ
Prog Clin Biol Res; 1988; 269():579-90. PubMed ID: 3393555
[No Abstract] [Full Text] [Related]
7. [Chemosensitivity test for bladder cancer in a nude-mice experimental system].
Yamauchi T; Okada K; Yoshida O; Kawai T
Hinyokika Kiyo; 1986 Dec; 32(12):1949-58. PubMed ID: 3825832
[TBL] [Abstract][Full Text] [Related]
8. [Arterial infusion chemotherapy for patients with advanced and moderately advanced cancer of urinary bladder].
Li Q; Xu X; Liu J
Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):308-9. PubMed ID: 10920993
[TBL] [Abstract][Full Text] [Related]
9. [A case of complete response was achieved with arterial infusion chemotherapy including CDDP, etoposide and pirarubicin].
Uekado Y; Watanabe T; Touge H; Inagaki T
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1075-7. PubMed ID: 8512337
[TBL] [Abstract][Full Text] [Related]
10. [The role of etoposide therapy in urogenital cancer].
Kawai K; Akaza H
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1929-35. PubMed ID: 8978800
[TBL] [Abstract][Full Text] [Related]
11. [In vitro and in vivo evaluation of inhibitory nucleic acid constructs for specific therapy of human urinary bladder carcinoma].
Kunze D; Füssel S; Meye A; Wuttig D; Krämer K; Kotzsch M; Toma M; Schwenzer B; Kausch I; Jocham D; Hakenberg OW; Grimm MO; Wirth MP
Urologe A; 2007 Sep; 46(9):1289. PubMed ID: 17665160
[No Abstract] [Full Text] [Related]
12. [Results of drug sensitivity test of UFT, doxorubicin and cisplatin using human urogenital cancers transplanted subcutaneously into nude mice].
Murahashi I; Hosoya Y; Mukae K; Honda M; Takasaki E
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3059-65. PubMed ID: 3142366
[TBL] [Abstract][Full Text] [Related]
13. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
Koch MO; Coussens D
Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
[No Abstract] [Full Text] [Related]
14. [Radiotherapy and chemotherapy in infiltrating bladder tumors].
Durdux C; Housset M
Rev Prat; 1997 Feb; 47(4):392-5. PubMed ID: 9114525
[TBL] [Abstract][Full Text] [Related]
15. [A case report of a young patient with invasive bladder cancer].
Nakashima M; Nishiyama H; Yagihashi Y; Yamamoto S; Kamoto T; Habuchi T; Ogawa O
Hinyokika Kiyo; 2003 Dec; 49(12):745-8. PubMed ID: 14978958
[TBL] [Abstract][Full Text] [Related]
16. Developing innovative strategies for advanced transitional cell carcinoma of the bladder.
Pollera CF; Nelli F
Expert Rev Anticancer Ther; 2006 Jan; 6(1):83-92. PubMed ID: 16375647
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
Balbay MD; Ozen H; Uluçay S; Sahin A; Ergen A; Koçal C; Remzi D
Int Urol Nephrol; 1993; 25(4):351-7. PubMed ID: 8276565
[TBL] [Abstract][Full Text] [Related]
18. [Small cell carcinoma of the urinary bladder: a case report].
Yokoyama S; Tsutahara K; Fukuhara S; Mori N; Hara T; Yamaguchi S; Adachi S
Hinyokika Kiyo; 2005 Jun; 51(6):403-5. PubMed ID: 16050481
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of magnetic resonance imaging for evaluation of therapeutic efficacy of bone metastases from bladder cancer: a case report].
Urushibara M; Tsukamoto T; Horiuchi S; Negishi T
Hinyokika Kiyo; 1998 Jul; 44(7):501-3. PubMed ID: 9752607
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.
Hadaschik BA; ter Borg MG; Jackson J; Sowery RD; So AI; Burt HM; Gleave ME
BJU Int; 2008 Jun; 101(11):1347-55. PubMed ID: 18384637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
